180 related articles for article (PubMed ID: 15456475)
21. Effect of recombinant factor VIIa on the hemostatic defect in dogs with hemophilia A, hemophilia B, and von Willebrand disease.
Brinkhous KM; Hedner U; Garris JB; Diness V; Read MS
Proc Natl Acad Sci U S A; 1989 Feb; 86(4):1382-6. PubMed ID: 2784006
[TBL] [Abstract][Full Text] [Related]
22. Recombinant factor VIIa in paediatric bleeding disorders--a 2006 review.
Mathew P; Young G
Haemophilia; 2006 Sep; 12(5):457-72. PubMed ID: 16919075
[TBL] [Abstract][Full Text] [Related]
23. Monitoring of hemostatic status in four patients being treated with recombinant factor VIIa.
Carr ME; Martin EJ; Kuhn JG; Ambrose H; Fern S; Bryant PC
Clin Lab; 2004; 50(9-10):529-38. PubMed ID: 15481628
[TBL] [Abstract][Full Text] [Related]
24. Recombinant activated factor VII (rFVIIa, NovoSeven).
Agarwal MB; Patnaik M
J Assoc Physicians India; 2005 Aug; 53():717-20. PubMed ID: 16398083
[TBL] [Abstract][Full Text] [Related]
25. Recombinant factor VIIa (r-FVIIa) in haemophilia management.
Rice KM; Savidge GF
Transfus Sci; 1996 Sep; 17(3):339-40. PubMed ID: 10184611
[No Abstract] [Full Text] [Related]
26. Use of recombinant factor VIIa for hip surgery in a patient with factor-VII deficiency. A case report.
Gopalan PK; Clohisy JC; Cashen AF; Eby CS
J Bone Joint Surg Am; 2007 Feb; 89(2):389-91. PubMed ID: 17272455
[No Abstract] [Full Text] [Related]
27. Recombinant activated factor VIIa and hemostasis in critical care: a focus on trauma.
Mohr AM; Holcomb JB; Dutton RP; Duranteau J
Crit Care; 2005; 9 Suppl 5(Suppl 5):S37-42. PubMed ID: 16221318
[TBL] [Abstract][Full Text] [Related]
28. Successful prophylaxis against intracranial hemorrhage using weekly administration of activated recombinant factor VII in a newborn with severe factor VII deficiency.
Farah RA; Hamod D; Melick N; Giansily-Blaizot M; Sallah S
J Thromb Haemost; 2007 Feb; 5(2):433-4. PubMed ID: 17109737
[No Abstract] [Full Text] [Related]
29. Recombinant activated factor VII: its mechanism of action and role in the control of hemorrhage.
Allen GA; Hoffman M; Roberts HR; Monroe DM
Can J Anaesth; 2002 Dec; 49(10):S7-14. PubMed ID: 12546000
[TBL] [Abstract][Full Text] [Related]
30. Enhanced in vitro procoagulant and antifibrinolytic potential of superactive variants of recombinant factor VIIa in severe hemophilia A.
Lisman T; de Groot PG; Lambert T; Røjkjaer R; Persson E
J Thromb Haemost; 2003 Oct; 1(10):2175-8. PubMed ID: 14521601
[TBL] [Abstract][Full Text] [Related]
31. [Recombinant activated factor VII in uncontrolled hemorrhage].
Colomina MJ; Altisent C; Guerrero E; Godet C
Med Clin (Barc); 2005 Feb; 124(4):156. PubMed ID: 15713248
[No Abstract] [Full Text] [Related]
32. Whole blood clot formation phenotypes in hemophilia A and rare coagulation disorders. Patterns of response to recombinant factor VIIa.
Sørensen B; Ingerslev J
J Thromb Haemost; 2004 Jan; 2(1):102-10. PubMed ID: 14717973
[TBL] [Abstract][Full Text] [Related]
33. Thromboelastography and recombinant factor VIIa-hemophilia and beyond.
Sørensen B; Ingerslev J
Semin Hematol; 2004 Jan; 41(1 Suppl 1):140-4. PubMed ID: 14872435
[TBL] [Abstract][Full Text] [Related]
34. Factor VIIa replacement therapy in factor VII deficiency.
Brummel Ziedins K; Rivard GE; Pouliot RL; Butenas S; Gissel M; Parhami-Seren B; Mann KG
J Thromb Haemost; 2004 Oct; 2(10):1735-44. PubMed ID: 15456484
[TBL] [Abstract][Full Text] [Related]
35. Recombinant factor VIIa (Novoseven) and the safety of treatment.
Roberts HR
Semin Hematol; 2001 Oct; 38(4 Suppl 12):48-50. PubMed ID: 11735111
[TBL] [Abstract][Full Text] [Related]
36. Potential role of recombinant factor FVIIa in prophylaxis in severe hemophilia patients with inhibitors.
Hedner U
J Thromb Haemost; 2006 Nov; 4(11):2498-500. PubMed ID: 16907841
[No Abstract] [Full Text] [Related]
37. [Place of recombinant activated factor VII in the treatment of severe haemorrhage in paediatric patients].
Veyckemans F
Ann Fr Anesth Reanim; 2009; 28(7-8):676-7. PubMed ID: 19574019
[No Abstract] [Full Text] [Related]
38. Successful use of recombinant factor VIIa in patient with severe haemophilia A during synovectomy.
Hedner U; Glazer S; Pingel K; Alberts KA; Blombäck M; Schulman S; Johnsson H
Lancet; 1988 Nov; 2(8621):1193. PubMed ID: 2903400
[No Abstract] [Full Text] [Related]
39. Recombinant factor VIIa for the treatment of congenital factor VII deficiency.
Hunault M; Bauer KA
Semin Thromb Hemost; 2000; 26(4):401-5. PubMed ID: 11092215
[TBL] [Abstract][Full Text] [Related]
40. Recombinant factor VIIa: its background, development and clinical use.
Hedner U
Curr Opin Hematol; 2007 May; 14(3):225-9. PubMed ID: 17414211
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
